DiCorleto Paul E 4
4 · CLEVELAND BIOLABS INC · Filed May 20, 2010
Insider Transaction Report
Form 4
DiCorleto Paul E
Director
Transactions
- Award
Common Stock
2010-05-18+7,267→ 7,267 total
Holdings
- 35,000
Stock Options (Right to Buy)
Exercise: $9.40From: 2007-06-12Exp: 2017-06-11→ Common Stock (35,000 underlying) - 35,000
Stock Options (Right to Buy)
Exercise: $5.88From: 2008-04-29Exp: 2018-04-28→ Common Stock (35,000 underlying) - 35,000
Stock Options (Right to Buy)
Exercise: $3.33From: 2009-06-25Exp: 2019-06-24→ Common Stock (35,000 underlying)